Edge Therapeutics, Inc. — Form D

Edge Therapeutics, Inc. of NEW PROVIDENCE, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2013-03-25. The offering totals $20.0M, of which $6.7M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (38)

Showing 25 of 38 people.

NameRoleLocation
Isaac Loch BlechDirectorNew Providence, NJ
Priya Loch JambhekarExecutive OfficerNew Providence, NJ
Brian A LeuthnerPromoterBerkeley Heights, NJ
Robert Loch MacdonaldPromoterBerkeley Heights, NJ
Carl J SorannoPromoterBerkeley Heights, NJ
Sol BarerDirectorNew Providence, NJ
Isaac J BlechDirectorBOSTON, MA
Andrew Loch EinhornExecutive OfficerBerkeley Heights, NJ
James J LoughlinDirectorBerkeley Heights, NJ
Albert N Marchio IIExecutive OfficerBerkeley Heights, NJ
Robert J SpiegelDirectorBerkeley Heights, NJ
Kurt J ContiDirectorBerkeley Heights, NJ
Robert Loch MacdonaldDirectorBerkeley Heights, NJ
Robert Loch MacdonaldExecutive OfficerBerkeley Heights, NJ
Herbert J FaleckExecutive OfficerBerkeley Heights, NJ
Carl J SorannoDirectorBerkeley Heights, NJ
Carl J SorannoExecutive OfficerBerkeley Heights, NJ
Brian A LeuthnerDirectorBerkeley Heights, NJ
Brian A LeuthnerExecutive OfficerBerkeley Heights, NJ
Kurt ContiDirectorNew Providence, NJ
Sol J BarerDirectorMendham, NJ
Brian LeuthnerDirectorNew Providence, NJ
Brian LeuthnerExecutive OfficerNew Providence, NJ
Brian LeuthnerPromoterNew Providence, NJ
R Loch McDonaldDirectorNEWARK, NJ

Other filings by this issuer (6)

FiledFormOfferingSold
2015-04-09D$56.0M$56.0M
2014-11-13D$25.0M$7.9M
2012-09-17D$3.0M$119K
2011-06-24D$2.8M$220K
2010-11-08D/A$2.0M$635K
2009-09-16D$2.0M$500K

More